Skip to main content
Top
Published in: Supportive Care in Cancer 3/2017

01-03-2017 | Original Article

Distress and psychological morbidity do not reduce over time in carers of patients with high-grade glioma

Authors: Georgia K. B. Halkett, Elizabeth A. Lobb, Thèrése Shaw, Michelle M. Sinclair, Lisa Miller, Elizabeth Hovey, Anna K. Nowak

Published in: Supportive Care in Cancer | Issue 3/2017

Login to get access

Abstract

Purpose

This study aimed to determine how carer distress and psychological morbidity change over time following a patient’s diagnosis of high-grade glioma (HGG) and identify factors associated with changes in carers’ psychological status.

Methods

Carers of patients with HGG planned for chemoradiotherapy were recruited to this longitudinal cohort study. Carers completed questionnaires during patients’ chemoradiotherapy and 3 and 6 months later including the following: the Distress Thermometer (DT); General Health Questionnaire-12 (GHQ-12); and three single-item questions about understanding of information presented by health professionals, confidence to care and preparedness to care for their relative/friend. Linear latent growth models were applied.

Results

The time 1 questionnaire was completed by 118 carers, of these 70 carers provided responses to the third time point. Carer distress and psychological morbidity were most prominent proximal to diagnosis, but remained high over time. Sixty-two percent of participants had moderate or high distress on the DT at time 1, 61% at time 2 and 58% at time 3. Scores on the DT and the GHQ-12 correlated significantly at all time points as did changes in scores over time (p < .001). However, for individual carers, the DT or GHQ-12 scores at one time point did not strongly predict scores at subsequent time points.

Conclusion

In carers of patients with HGG, distress levels are consistently high and cannot be predicted at any time point. Carers should be monitored over time to identify evolving psychological morbidity. The single-item DT correlates highly with GHQ-12 scores and is a suitable tool for rapid repeated screening.
Literature
1.
go back to reference Boele FW, Heimans JJ, Aaronson NK, Taphoorn MJ, Postma TJ, Reijneveld JC, Klein M (2013) Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study. J Neuro-Oncol 115:87–94CrossRef Boele FW, Heimans JJ, Aaronson NK, Taphoorn MJ, Postma TJ, Reijneveld JC, Klein M (2013) Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study. J Neuro-Oncol 115:87–94CrossRef
2.
go back to reference Catt S, Chalmers A, Fallowfield L (2008) Psychosocial and supportive-care needs in high-grade glioma. Lancet Oncology 9:884–891CrossRefPubMed Catt S, Chalmers A, Fallowfield L (2008) Psychosocial and supportive-care needs in high-grade glioma. Lancet Oncology 9:884–891CrossRefPubMed
3.
go back to reference Gessler S, Low J, Daniells E, Williams R, Brough V, Tookman A, Jones L (2007) Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? Psychooncology 17:538–547CrossRef Gessler S, Low J, Daniells E, Williams R, Brough V, Tookman A, Jones L (2007) Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? Psychooncology 17:538–547CrossRef
4.
go back to reference Goldberg DP, Gater R, Sartorius N, Ustun T, Piccinelli M, Gureje O, Rutter C (1997) The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27:191–197CrossRefPubMed Goldberg DP, Gater R, Sartorius N, Ustun T, Piccinelli M, Gureje O, Rutter C (1997) The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27:191–197CrossRefPubMed
5.
go back to reference Halkett GK, Lobb EA, Rogers MM, Shaw T, Long AP, Wheeler HR, Nowak AK (2015) Predictors of distress and poorer quality of life in high grade glioma patients. Patient Educ Couns 98:525–532CrossRefPubMed Halkett GK, Lobb EA, Rogers MM, Shaw T, Long AP, Wheeler HR, Nowak AK (2015) Predictors of distress and poorer quality of life in high grade glioma patients. Patient Educ Couns 98:525–532CrossRefPubMed
6.
go back to reference Hudson P, Trauer T, Kelly B, O’Connor M, Thomas K, Zordan R, Summers M (2015) Reducing the psychological distress of family caregivers of home based palliative care patients: longer term effects from a randomised controlled trial. Psychooncology 24:19–24CrossRefPubMed Hudson P, Trauer T, Kelly B, O’Connor M, Thomas K, Zordan R, Summers M (2015) Reducing the psychological distress of family caregivers of home based palliative care patients: longer term effects from a randomised controlled trial. Psychooncology 24:19–24CrossRefPubMed
7.
go back to reference Jacobs DI, Kumthekar P, Stell BV, Grimm SA, Rademaker AW, Rice L, Chandler JP, Muro K, Marymont M, Helenowski IB, Wagner LI, Raizer JJ (2014) Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden. Neuro-Oncology Pract 1:47–54CrossRef Jacobs DI, Kumthekar P, Stell BV, Grimm SA, Rademaker AW, Rice L, Chandler JP, Muro K, Marymont M, Helenowski IB, Wagner LI, Raizer JJ (2014) Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden. Neuro-Oncology Pract 1:47–54CrossRef
8.
go back to reference Janda M, Eakin E, Bailey L, Walker D, Troy K (2006) Supportive care needs of people with brain tumours and their carers. Support Care Cancer 14:1094–1103CrossRefPubMed Janda M, Eakin E, Bailey L, Walker D, Troy K (2006) Supportive care needs of people with brain tumours and their carers. Support Care Cancer 14:1094–1103CrossRefPubMed
9.
go back to reference Johnson DR, Ma DJ, Buckner JC, Hammack JE (2012) Conditional probability of long-term survival in glioblastoma. Cancer 118:5608–5613CrossRefPubMed Johnson DR, Ma DJ, Buckner JC, Hammack JE (2012) Conditional probability of long-term survival in glioblastoma. Cancer 118:5608–5613CrossRefPubMed
10.
go back to reference Keir S, Calhoun-Eagan R, Swartz U, Friedman H (2008) Screening for distress in patients with brain cancer. Psychooncology 17:621–625CrossRefPubMed Keir S, Calhoun-Eagan R, Swartz U, Friedman H (2008) Screening for distress in patients with brain cancer. Psychooncology 17:621–625CrossRefPubMed
11.
go back to reference Lobb EA, Halkett GK, Nowak AK (2011) Patient and caregiver perceptions of communication of prognosis in high grade glioma. J Neuro-Oncol 104:315–322CrossRef Lobb EA, Halkett GK, Nowak AK (2011) Patient and caregiver perceptions of communication of prognosis in high grade glioma. J Neuro-Oncol 104:315–322CrossRef
12.
go back to reference Long A, Halkett G, Lobb E, Shaw T, Hovey E, Nowak A (2016) Carers of patients with high-grade glioma report high levels of distress, unmet needs, and psychological morbidity during patient chemoradiotherapy. Neuro Oncol Pract 3:105–112CrossRef Long A, Halkett G, Lobb E, Shaw T, Hovey E, Nowak A (2016) Carers of patients with high-grade glioma report high levels of distress, unmet needs, and psychological morbidity during patient chemoradiotherapy. Neuro Oncol Pract 3:105–112CrossRef
13.
go back to reference McConigley R, Halkett G, Lobb E, Nowak A (2010) Caring for someone with high-grade glioma: a time of rapid change for caregivers. Palliat Med 24:473–479CrossRefPubMed McConigley R, Halkett G, Lobb E, Nowak A (2010) Caring for someone with high-grade glioma: a time of rapid change for caregivers. Palliat Med 24:473–479CrossRefPubMed
14.
go back to reference Muñoz C, Juarez G, Muñoz ML, Portnow J, Fineman I, Badie B, Mamelak A, Ferrell B (2008) The quality of life of patients with malignant gliomas and their caregivers. Soc Work Health Care 47:455–478CrossRefPubMed Muñoz C, Juarez G, Muñoz ML, Portnow J, Fineman I, Badie B, Mamelak A, Ferrell B (2008) The quality of life of patients with malignant gliomas and their caregivers. Soc Work Health Care 47:455–478CrossRefPubMed
15.
go back to reference Nipp RD, El-Jawahri A, Fishbein JN, Gallagher ER, Stagl JM, Park ER, Jackson VA, Pirl WF, Greer JA, Temel JS (2016) Factors associated with depression and anxiety symptoms in family caregivers of patients with incurable cancer. Ann Oncol 27:1607–1612CrossRefPubMed Nipp RD, El-Jawahri A, Fishbein JN, Gallagher ER, Stagl JM, Park ER, Jackson VA, Pirl WF, Greer JA, Temel JS (2016) Factors associated with depression and anxiety symptoms in family caregivers of patients with incurable cancer. Ann Oncol 27:1607–1612CrossRefPubMed
16.
go back to reference Pasacreta JV, Barg F, Nuamah I, McCorkle R (2000) Participant characteristics before and 4 months after attendance at a family caregiver cancer education program. Cancer Nurs 23:295–303CrossRefPubMed Pasacreta JV, Barg F, Nuamah I, McCorkle R (2000) Participant characteristics before and 4 months after attendance at a family caregiver cancer education program. Cancer Nurs 23:295–303CrossRefPubMed
17.
go back to reference Petruzzi A, Finocchiaro CY, Lamperti E, Salmaggi A (2013) Living with a brain tumor: reaction profiles in patients and their caregivers. Support Care Cancer 21:1105–1111CrossRefPubMed Petruzzi A, Finocchiaro CY, Lamperti E, Salmaggi A (2013) Living with a brain tumor: reaction profiles in patients and their caregivers. Support Care Cancer 21:1105–1111CrossRefPubMed
18.
go back to reference Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R (2013) The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma. Neuro-Oncology 15:635–643CrossRefPubMedPubMedCentral Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R (2013) The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma. Neuro-Oncology 15:635–643CrossRefPubMedPubMedCentral
19.
go back to reference Schlomer GL, Bauman S, Card NA (2010) Best practices for missing data management in counseling psychology. J Couns Psychol 57:1–10CrossRefPubMed Schlomer GL, Bauman S, Card NA (2010) Best practices for missing data management in counseling psychology. J Couns Psychol 57:1–10CrossRefPubMed
20.
go back to reference Schmer C, Ward-Smith P, Latham S, Salacz M (2008) When a family member has a malignant brain tumor: the caregiver perspective. J Neurosci Nurs 40:78–84CrossRefPubMed Schmer C, Ward-Smith P, Latham S, Salacz M (2008) When a family member has a malignant brain tumor: the caregiver perspective. J Neurosci Nurs 40:78–84CrossRefPubMed
21.
go back to reference Sizoo EM, Pasman HR, Dirven L, Marosi C, Grisold W, Stockhammer G, Egeter J, Grant R, Chang S, Heimans JJ, Deliens L, Reijneveld JC, Taphoorn MJ (2014) The end-of-life phase of high-grade glioma patients: a systematic review. Support Care Cancer 22:847–857CrossRefPubMed Sizoo EM, Pasman HR, Dirven L, Marosi C, Grisold W, Stockhammer G, Egeter J, Grant R, Chang S, Heimans JJ, Deliens L, Reijneveld JC, Taphoorn MJ (2014) The end-of-life phase of high-grade glioma patients: a systematic review. Support Care Cancer 22:847–857CrossRefPubMed
22.
go back to reference Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M, Belanger K, Brandes A (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M, Belanger K, Brandes A (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed
23.
go back to reference Thomas C, Morris SM, Harman JC (2002) Companions through cancer: the care given by informal carers in cancer contexts. Soc Sci Med 54:529–544CrossRefPubMed Thomas C, Morris SM, Harman JC (2002) Companions through cancer: the care given by informal carers in cancer contexts. Soc Sci Med 54:529–544CrossRefPubMed
24.
go back to reference Trad W, Koh ES, Daher M, Bailey A, Kastelan M, Legge D, Fleet M, Simpson GK, Hovey E (2015) Screening for psychological distress in adult primary brain tumor patients and caregivers: considerations for cancer care coordination. Frontiers Oncol 5:203CrossRef Trad W, Koh ES, Daher M, Bailey A, Kastelan M, Legge D, Fleet M, Simpson GK, Hovey E (2015) Screening for psychological distress in adult primary brain tumor patients and caregivers: considerations for cancer care coordination. Frontiers Oncol 5:203CrossRef
25.
go back to reference Wasner M, Paal P, Borasio GD (2013) Psychosocial care for the caregivers of primary malignant brain tumor patients. J Social Work end-of-Life Palliat Care 9:74–95CrossRef Wasner M, Paal P, Borasio GD (2013) Psychosocial care for the caregivers of primary malignant brain tumor patients. J Social Work end-of-Life Palliat Care 9:74–95CrossRef
26.
go back to reference Wilczek K, Mangan H, Barnett C, White K (2016) Meeting the needs of family carers in the bone marrow transplant setting. Bone Marrow Transplant 51:S520CrossRef Wilczek K, Mangan H, Barnett C, White K (2016) Meeting the needs of family carers in the bone marrow transplant setting. Bone Marrow Transplant 51:S520CrossRef
27.
go back to reference Zwahlen D, Hagenbuch N, Carley MI, Recklitis CJ, Buchi S (2008) Screening cancer patients’ families with the distress thermometer (DT): a validation study. Psycho-Oncology 17:959–966CrossRefPubMed Zwahlen D, Hagenbuch N, Carley MI, Recklitis CJ, Buchi S (2008) Screening cancer patients’ families with the distress thermometer (DT): a validation study. Psycho-Oncology 17:959–966CrossRefPubMed
Metadata
Title
Distress and psychological morbidity do not reduce over time in carers of patients with high-grade glioma
Authors
Georgia K. B. Halkett
Elizabeth A. Lobb
Thèrése Shaw
Michelle M. Sinclair
Lisa Miller
Elizabeth Hovey
Anna K. Nowak
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3478-6

Other articles of this Issue 3/2017

Supportive Care in Cancer 3/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine